Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Lung Cancer

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 177 articles: HTML format Text format

Single Articles

March 2010
1. TISHELMAN C , Lovgren M, Broberger E, Hamberg K, et al
   Are the Most Distressing Concerns of Patients With Inoperable Lung Cancer Adequately Assessed? A Mixed-Methods Analysis.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. SCAGLIOTTI G , Novello S, von Pawel J, Reck M, et al
   Phase III Study of Carboplatin and Paclitaxel Alone or With Sorafenib in Advanced Non-Small-Cell Lung Cancer.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. EARLE CC , Chretien Y, Morris C, Ayanian JZ, et al
   Employment Among Survivors of Lung Cancer and Colorectal Cancer.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. HU Z , Chen X, Zhao Y, Tian T, et al
   Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non-Small-Cell Lung Cancer.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
5. LEVINE AM , Seaberg EC, Hessol NA, Preston-Martin S, et al
   HIV As a Risk Factor for Lung Cancer in Women: Data From the Women's Interagency HIV Study.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. SORIA JC , Smit E, Khayat D, Besse B, et al
   Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. SLATORE CG , Chien JW, Au DH, Satia JA, et al
   Lung Cancer and Hormone Replacement Therapy: Association in the Vitamins and Lifestyle Study.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. TAN DS , Ng QS, Tan IB, Lim ST, et al
   Truth About ERCC1 in Lung Cancer.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles   
   
   
   
9. WOLFF N , Kabbani W, Bradley T, Raj G, et al
   Sirolimus and temsirolimus for epithelioid angiomyolipoma.
   J Clin Oncol. 2010;28:e65-8.
   PubMed     Text format     Related articles   
   
   
   
10. GOVINDAN R
    INTERESTing biomarker to select IDEAL patients for epidermal growth factor receptor tyrosine kinase inhibitors: yes, for EGFR mutation analysis, others, I PASS.
    J Clin Oncol. 2010;28:713-5.
    PubMed     Text format     Related articles   
    
    
    
11. VAN BAARDWIJK A , Wanders S, Boersma L, Borger J, et al
    Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. HAURA EB , Tanvetyanon T, Chiappori A, Williams C, et al
    Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
13. FRIEDEL G , Budach W, Dippon J, Spengler W, et al
    Phase II Trial of a Trimodality Regimen for Stage III Non-Small-Cell Lung Cancer Using Chemotherapy As Induction Treatment With Concurrent Hyperfractionated Chemoradiation With Carboplatin and Paclitaxel Followed by Subsequent Resection: A Single-Cent
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. LYNCH TJ , Patel T, Dreisbach L, McCleod M, et al
    Cetuximab and First-Line Taxane/Carboplatin Chemotherapy in Advanced Non-Small-Cell Lung Cancer: Results of the Randomized Multicenter Phase III Trial BMS099.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. KHAMBATA-FORD S , Harbison CT, Hart LL, Awad M, et al
    Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. SHEPHERD FA , Tsao MS
    Epidermal Growth Factor Receptor Biomarkers in Non-Small-Cell Lung Cancer: A Riddle, Wrapped in a Mystery, Inside an Enigma.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
17. ARAUJO AM
    Pemetrexed Plus Bevacizumab for Second-Line Therapy of Non-Small-Cell Lung Cancer: The Importance of Patient Selection.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
18. DAHLBERG SE , Sandler AB, Brahmer JR, Schiller JH, et al
    Clinical Course of Advanced Non-Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4599.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. BLASBERG JD , Pass HI, Goparaju CM, Flores RM, et al
    Reduction of Elevated Plasma Osteopontin Levels With Resection of Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. GRILLS IS , Mangona VS, Welsh R, Chmielewski G, et al
    Outcomes After Stereotactic Lung Radiotherapy or Wedge Resection for Stage I Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. ALTORKI NK
    Stereotactic Body Radiation Therapy Versus Wedge Resection for Medically Inoperable Stage I Lung Cancer: Tailored Therapy or One Size Fits All?
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
22. TIMMERMAN RD
    Surgery Versus Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer: Who's Down for the Count?
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    December 2009
23. TAKEDA K , Hida T, Sato T, Ando M, et al
    Randomized Phase III Trial of Platinum-Doublet Chemotherapy Followed by Gefitinib Compared With Continued Platinum-Doublet Chemotherapy in Japanese Patients With Advanced Non-Small-Cell Lung Cancer: Results of a West Japan Thoracic Oncology Group Tria
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. CHRISCHILLES EA , Pendergast JF, Kahn KL, Wallace RB, et al
    Adverse Events Among the Elderly Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. DOUILLARD JY , Shepherd FA, Hirsh V, Mok T, et al
    Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. SIMON GR
    Treatment of Older Patients With Non-Small-Cell Lung Cancer: Walking the Therapeutic Tightrope.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
27. LEE YJ , Cho BC, Jee SH, Moon JW, et al
    Impact of Environmental Tobacco Smoke on the Incidence of Mutations in Epidermal Growth Factor Receptor Gene in Never-Smoker Patients With Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
28. HANRAHAN EO , Lin HY, Kim ES, Yan S, et al
    Distinct Patterns of Cytokine and Angiogenic Factor Modulation and Markers of Benefit for Vandetanib and/or Chemotherapy in Patients With Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. JACKMAN D , Pao W, Riely GJ, Engelman JA, et al
    Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. ARRIAGADA R , Dunant A, Pignon JP, Bergman B, et al
    Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. BUTTS CA , Ding K, Seymour L, Twumasi-Ankrah P, et al
    Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non-Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. RAMALINGAM SS , Maitland ML, Frankel P, Argiris AE, et al
    Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. BOGART JA , Hodgson L, Seagren SL, Blackstock AW, et al
    Phase I Study of Accelerated Conformal Radiotherapy for Stage I Non-Small-Cell Lung Cancer in Patients With Pulmonary Dysfunction: CALGB 39904.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. DE LIMA ARAUJO LH , Ferreira CG
    Platinum-Based Second-Line Treatment in Non-Small-Cell Lung Cancer: An Old New Kid on the Block?
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
35. DOUILLARD JY
    Adjuvant Chemotherapy for Non-Small-Cell Lung Cancer: It Does Not Always Fade With Time.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
36. AZZOLI CG , Baker S Jr, Temin S, Pao W, et al
    American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. GOSS GD , Arnold A, Shepherd FA, Dediu M, et al
    Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non-Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. SPIGEL DR , Hainsworth JD, Yardley DA, Raefsky E, et al
    Tracheoesophageal Fistula Formation in Patients With Lung Cancer Treated With Chemoradiation and Bevacizumab.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. REYNOLDS C , Obasaju C, Schell MJ, Li X, et al
    Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. LARA-GUERRA H , Waddell TK, Salvarrey MA, Joshua AM, et al
    Phase II Study of Preoperative Gefitinib in Clinical Stage I Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. SASSE AD , Lima JP, Sasse EC, Santos LV, et al
    Duration of Chemotherapy for Metastatic Non-Small-Cell Lung Cancer: More May Be Not Better.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    October 2009
42. MOVSAS B , Moughan J, Sarna L, Langer C, et al
    Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non-Small-Cell Lung Cancer: An Analysis of RTOG 9801.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. ADJEI AA , Mandrekar SJ, Dy GK, Molina JR, et al
    Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non-Small-Cell Lung Cancer: NCCTG and SWOG Study N0426.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. CRUCITTI A , Feliciani C, Grossi U, La Greca A, et al
    Paraneoplastic Acrokeratosis (Bazex Syndrome) in Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
45. YOO SS , Choi JE, Lee WK, Choi YY, et al
    Polymorphisms in the CASPASE Genes and Survival in Patients With Early-Stage Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. HORN L , Dahlberg SE, Sandler AB, Dowlati A, et al
    Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
47. LEIDNER RS , Fu P, Clifford B, Hamdan A, et al
    Genetic Abnormalities of the EGFR Pathway in African American Patients With Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. LEE SM , Rudd R, Woll PJ, Ottensmeier C, et al
    Randomized Double-Blind Placebo-Controlled Trial of Thalidomide in Combination With Gemcitabine and Carboplatin in Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. MOK TS , Wu YL, Yu CJ, Zhou C, et al
    Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. SOCINSKI MA , Langer CJ, Huang JE, Kolb MM, et al
    Safety of Bevacizumab in Patients With Non-Small-Cell Lung Cancer and Brain Metastases.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
51. SOCINSKI MA , Smit EF, Lorigan P, Konduri K, et al
    Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. ROSSI G , Papotti M, Barbareschi M, Graziano P, et al
    Morphology and a Limited Number of Immunohistochemical Markers May Efficiently Subtype Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
53. LILENBAUM R , Wang X, Gu L, Kirshner J, et al
    Randomized Phase II Trial of Docetaxel Plus Cetuximab or Docetaxel Plus Bortezomib in Patients With Advanced Non-Small-Cell Lung Cancer and a Performance Status of 2: CALGB 30402.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. BOOTH CM , Le Maitre A, Ding K, Farn K, et al
    Presentation of nonfinal results of randomized controlled trials at major oncology meetings.
    J Clin Oncol. 2009;27:3938-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. GIACCONE G , Zatloukal P, Roubec J, Floor K, et al
    Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. HOLM B , Mellemgaard A, Skov T, Skov BG, et al
    Different Impact of Excision Repair Cross-Complementation Group 1 on Survival in Male and Female Patients With Inoperable Non-Small-Cell Lung Cancer Treated With Carboplatin and Gemcitabine.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. JANG RW , Le Maitre A, Ding K, Winton T, et al
    Quality-Adjusted Time Without Symptoms or Toxicity Analysis of Adjuvant Chemotherapy in Non-Small-Cell Lung Cancer: An Analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. TITULAER MJ , Klooster R, Potman M, Sabater L, et al
    SOX Antibodies in Small-Cell Lung Cancer and Lambert-Eaton Myasthenic Syndrome: Frequency and Relation With Survival.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. ZEE YK , Chin TM, Wong AS
    Fatal Cystic Change of Brain Metastasis After Response to Gefitinib in Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
60. SHAW AT , Yeap BY, Mino-Kenudson M, Digumarthy SR, et al
    Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Who Harbor EML4-ALK.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. HORN L , Pao W
    EML4-ALK: Honing In on a New Target in Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
62. PIRL WF , Solis J, Greer J, Sequist L, et al
    Epidermal growth factor receptor tyrosine kinase inhibitors and depression.
    J Clin Oncol. 2009;27:e49-50.
    PubMed     Text format     Related articles   
    
    
    
63. BLUMENSCHEIN GR JR , Gatzemeier U, Fossella F, Stewart DJ, et al
    Phase II, Multicenter, Uncontrolled Trial of Single-Agent Sorafenib in Patients With Relapsed or Refractory, Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
64. BORGHAEI H , Alpaugh K, Hedlund G, Forsberg G, et al
    Phase I Dose Escalation, Pharmacokinetic and Pharmacodynamic Study of Naptumomab Estafenatox Alone in Patients With Advanced Cancer and With Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. SCHILLER JH , Larson T, Ou SH, Limentani S, et al
    Efficacy and Safety of Axitinib in Patients With Advanced Non-Small-Cell Lung Cancer: Results From a Phase II Study.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
66. HAUGNES HS , Aass N, Fossa SD, Dahl O, et al
    Pulmonary function in long-term survivors of testicular cancer.
    J Clin Oncol. 2009;27:2779-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. TOMIDA S , Takeuchi T, Shimada Y, Arima C, et al
    Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis.
    J Clin Oncol. 2009;27:2793-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. SMITH BD , Smith GL, Hurria A, Hortobagyi GN, et al
    Future of cancer incidence in the United States: burdens upon an aging, changing nation.
    J Clin Oncol. 2009;27:2758-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. ABALI H , Disel U, Kose F, Sezer A, et al
    Immediate or delayed docetaxel: does progression-free survival really reflect two strategies?
    J Clin Oncol. 2009;27:2889.
    PubMed     Text format     Related articles   
    
    
    
70. SILVESTRIS N , Di Palma T, Rabitti C, Pericoli MN, et al
    Rapidly Progressive Coma in Leptomeningeal Carcinomatosis From Undiagnosed Bronchioloalveolar Carcinoma.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
71. DHRUVA N , Socinski MA
    Carcinomatous Meningitis in Non-Small-Cell Lung Cancer: Response to High-Dose Erlotinib.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
72. GEMICI C
    Tumor lysis syndrome in solid tumors.
    J Clin Oncol. 2009;27:2738-9.
    PubMed     Text format     Related articles   
    
    
    May 2009
73. SOON YY , Stockler MR, Askie LM, Boyer MJ, et al
    Duration of Chemotherapy for Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. GANDARA DR , Kawaguchi T, Crowley J, Moon J, et al
    Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non-Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. SOCINSKI MA
    Re-Evaluating Duration of Therapy in Advanced Non-Small-Cell Lung Cancer: Is It Really Duration or Is It More About Timing and Exposure?
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
76. SCHILLER JH , Ramalingam SS
    Duration of Chemotherapy for Metastatic Non-Small-Cell Lung Cancer: More May Be Better After All.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
77. PATEL JD , Hensing TA, Rademaker A, Hart EM, et al
    Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. GRONBERG BH , Bremnes RM, Flotten O, Amundsen T, et al
    Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. LEPPALUOTO PA
    Nonsmoking: A Surrogate Factor in Primary Lung Cancer in Survivors of Cervical Adenocarcinoma?
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
80. BAI H , Mao L, Wang HS, Zhao J, et al
    Epidermal Growth Factor Receptor Mutations in Plasma DNA Samples Predict Tumor Response in Chinese Patients With Stages IIIB to IV Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. HUANG YT , Heist RS, Chirieac LR, Lin X, et al
    Genome-Wide Analysis of Survival in Early-Stage Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. YEE J , Sadar MD, Sin DD, Kuzyk M, et al
    Connective Tissue-Activating Peptide III: A Novel Blood Biomarker for Early Lung Cancer Detection.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. SEQUIST LV , Engelman JA, Lynch TJ
    Toward Noninvasive Genomic Screening of Lung Cancer Patients.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
84. BAUMANN P , Nyman J, Hoyer M, Wennberg B, et al
    Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. DUNCAN MW
    Place for Biochemical Markers in Early Stage Lung Cancer Detection?
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
86. KATZ A , Saad ED
    CALGB 9633: an underpowered trial with a methodologically questionable conclusion.
    J Clin Oncol. 2009;27:2300-1.
    PubMed     Text format     Related articles   
    
    
    April 2009
87. KARP DD , Paz-Ares LG, Novello S, Haluska P, et al
    Phase II Study of the Anti-Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. YUAN X , Liao Z, Liu Z, Wang LE, et al
    Single Nucleotide Polymorphism at rs1982073:T869C of the TGF{beta}1 Gene Is Associated With the Risk of Radiation Pneumonitis in Patients With Non-Small-Cell Lung Cancer Treated With Definitive Radiotherapy.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. LE QT , Moon J, Redman M, Williamson SK, et al
    Phase II Study of Tirapazamine, Cisplatin, and Etoposide and Concurrent Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer: SWOG 0222.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. LARA PN JR , Natale R, Crowley J, Lenz HJ, et al
    Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. RUSTHOVEN KE , Kavanagh BD, Burri SH, Chen C, et al
    Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
    J Clin Oncol. 2009;27:1579-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. GIORGI F , Bascioni R
    Another infusion of hope.
    J Clin Oncol. 2009;27:1722-3.
    PubMed     Text format     Related articles   
    
    
    March 2009
93. NATALE RB , Bodkin D, Govindan R, Sleckman BG, et al
    Vandetanib Versus Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: Results From a Two-Part, Double-Blind, Randomized Phase II Study.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. MIKSAD RA , Gonen M, Lynch TJ, Roberts TG Jr, et al
    Interpreting Trial Results in Light of Conflicting Evidence: A Bayesian Analysis of Adjuvant Chemotherapy for Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. SMIT EF , Burgers SA, Biesma B, Smit HJ, et al
    Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. YAN TD , Black D, Bannon PG, McCaughan BC, et al
    Systematic Review and Meta-Analysis of Randomized and Nonrandomized Trials on Safety and Efficacy of Video-Assisted Thoracic Surgery Lobectomy for Early-Stage Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. GOSS G , Ferry D, Wierzbicki R, Laurie SA, et al
    Randomized Phase II Study of Gefitinib Compared With Placebo in Chemotherapy-Naive Patients With Advanced Non-Small-Cell Lung Cancer and Poor Performance Status.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. ECKARDT JR , Bentsion DL, Lipatov ON, Polyakov IS, et al
    Phase II Study of Picoplatin as Second-Line Therapy for Patients With Small-Cell Lung Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. HUGHES AN , O'Brien ME, Petty WJ, Chick JB, et al
    Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers.
    J Clin Oncol. 2009;27:1220-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. DI MAIO M , Chiodini P, Georgoulias V, Hatzidaki D, et al
     Meta-Analysis of Single Agent Chemotherapy Compared With Combination Chemotherapy as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. LEBANONY D , Benjamin H, Gilad S, Ezagouri M, et al
     Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Non-Squamous Non-Small-Cell Lung Carcinoma.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. CAPPUZZO F , Marchetti A, Skokan M, Rossi E, et al
     Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non-Small-Cell Lung Cancer Patients.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
103. SANDLER AB , Schiller JH, Gray R, Dimery I, et al
     Retrospective Evaluation of the Clinical and Radiographic Risk Factors Associated With Severe Pulmonary Hemorrhage in First-Line Advanced, Unresectable Non-Small-Cell Lung Cancer Treated With Carboplatin and Paclitaxel Plus Bevacizumab.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. INOUE A , Kobayashi K, Usui K, Maemondo M, et al
     First-Line Gefitinib for Patients With Advanced Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. LANGER CJ
     The "Lazarus Response" in Treatment-Naive, Poor Performance Status Patients With Non-Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Mutation.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles   
     
     
     
106. ELLIS J , Lin J, Walsh A, Lo C, et al
     Predictors of referral for specialized psychosocial oncology care in patients with metastatic cancer: the contributions of age, distress, and marital status.
     J Clin Oncol. 2009;27:699-705.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. WINER E , Gralow J, Diller L, Karlan B, et al
     Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
     J Clin Oncol. 2009;27:812-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. CHEN G , Huynh M, Fehrenbacher L, West H, et al
     Phase II Trial of Irinotecan and Carboplatin for Extensive or Relapsed Small-Cell Lung Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. RECK M , von Pawel J, Zatloukal P, Ramlau R, et al
     Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer: AVAiL.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. ZHU ZH , Sun BY, Ma Y, Shao JY, et al
     Three Immunomarker Support Vector Machines-Based Prognostic Classifiers for Stage IB Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. BIELACK SS , Kempf-Bielack B, Branscheid D, Carrle D, et al
     Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients.
     J Clin Oncol. 2009;27:557-65.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. KOSCHMIEDER S , Halmos B, Levantini E, Tenen DG, et al
     Dysregulation of the C/EBPalpha differentiation pathway in human cancer.
     J Clin Oncol. 2009;27:619-28.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
113. NOSE N , Sugio K, Oyama T, Nozoe T, et al
     Association between estrogen receptor-beta expression and epidermal growth factor receptor mutation in the postoperative prognosis of adenocarcinoma of the lung.
     J Clin Oncol. 2009;27:411-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. ANAGNOSTOU VK , Syrigos KN, Bepler G, Homer RJ, et al
     Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma.
     J Clin Oncol. 2009;27:271-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. CARTER RE , Huang P
     Cautionary note regarding the use of CIs obtained from Kaplan-Meier survival curves.
     J Clin Oncol. 2009;27:174-5.
     PubMed     Text format     Related articles   
     
     
     December 2008
116. FIDIAS PM , Dakhil SR, Lyss AP, Loesch DM, et al
     Phase III Study of Immediate Compared With Delayed Docetaxel After Front-Line Therapy With Gemcitabine Plus Carboplatin in Advanced Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. TAKANO T , Ota S, Hori A, Seki N, et al
     Can Epidermal Growth Factor Receptor-Fluorescent in Situ Hybridization Predict Clinical Benefit From Cetuximab Treatment in Patients With Non-Small-Cell Lung Cancer?
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
118. CRABB SJ , Patsios D, Sauerbrei E, Ellis PM, et al
     Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. SLOTMAN BJ , Mauer ME, Bottomley A, Faivre-Finn C, et al
     Prophylactic Cranial Irradiation in Extensive Disease Small-Cell Lung Cancer: Short-Term Health-Related Quality of Life and Patient Reported Symptoms--Results of an International Phase III Randomized Controlled Trial by the EORTC Radiation Oncology and L
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. RIELY GJ , Rizvi NA, Kris MG, Milton DT, et al
     Randomized Phase II Study of Pulse Erlotinib Before or After Carboplatin and Paclitaxel in Current or Former Smokers With Advanced Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. TAKANO T , Fukui T, Ohe Y, Tsuta K, et al
     EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan.
     J Clin Oncol. 2008;26:5589-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
122. MILLS ME , Murray LJ, Johnston BT, Cardwell C, et al
     Does a Patient-Held Quality-of-Life Diary Benefit Patients With Inoperable Lung Cancer?
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. NOH GY , Choe DH, Kim CH, Lee JC, et al
     Fatal Tumor Lysis Syndrome During Radiotherapy for Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
124. BOOTH CM , Cescon DW, Wang L, Tannock IF, et al
     Evolution of the randomized controlled trial in oncology over three decades.
     J Clin Oncol. 2008;26:5458-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. GRUNBERG SM
     Giving permission.
     J Clin Oncol. 2008;26:5477-8.
     PubMed     Text format     Related articles   
     
     
     
126. KIM HT , Lee JE, Shin ES, Yoo YK, et al
     Effect of BRCA1 Haplotype on Survival of Non-Small-Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. AGARWAL R , Gupta R, Bhaskar A, Sharma A, et al
     Synchronous Presentation of Multiple Myeloma and Lung Cancer.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
128. HANNA N , Neubauer M, Yiannoutsos C, McGarry R, et al
     Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non-Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. HOTTA K , Kiura K, Takigawa N, Matsuo K, et al
     Paradoxical Clinical Effects of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Acute Myelogenous Leukemia.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
130. CHENG Z , Yin H, Du J, Yue X, et al
     Bilateral breast metastasis from small-cell carcinoma of the ovary.
     J Clin Oncol. 2008;26:5129-30.
     PubMed     Text format     Related articles   
     
     
     
131. SONG YM , Sung J, Cho HJ
     Reduction and cessation of cigarette smoking and risk of cancer: a cohort study of Korean men.
     J Clin Oncol. 2008;26:5101-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
132. HEYMACH JV , Paz-Ares L, De Braud F, Sebastian M, et al
     Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. HEIST RS , Zhou W, Wang Z, Liu G, et al
     Circulating 25-Hydroxyvitamin D, VDR Polymorphisms, and Survival in Advanced Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. JANKU F , Bird B
     Personalized Medicine in Advanced Non-Small-Cell Lung Cancer: Reality or Wishful Thinking?
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
135. INOUE A , Sugawara S, Yamazaki K, Maemondo M, et al
     Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. BHUTANI M , Pathak AK, Mao L
     SWOG S0023: what meets the eye may be only half the truth.
     J Clin Oncol. 2008;26:4848-9.
     PubMed     Text format     Related articles   
     
     
     
137. KUO YW , Chen KY, Chang YL, Lee LN, et al
     Small-cell lung carcinoma presenting with otalgia and hearing impairment.
     J Clin Oncol. 2008;26:4690-2.
     PubMed     Text format     Related articles   
     
     
     
138. TANVETYANON T , Eikman EA, Sommers E, Robinson L, et al
     Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-cell lung cancer.
     J Clin Oncol. 2008;26:4610-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. PATZ EF JR
     Does computed tomography or positron emission tomography response after neoadjuvant chemotherapy for resectable non-small-cell lung cancer predict survival?
     J Clin Oncol. 2008;26:4542-3.
     PubMed     Text format     Related articles   
     
     
     September 2008
140. BEZJAK A , Lee CW, Ding K, Brundage M, et al
     Quality-of-Life Outcomes for Adjuvant Chemotherapy in Early-Stage Non-Small-Cell Lung Cancer: Results From a Randomized Trial, JBR.10.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. STRAUSS GM , Herndon JE 2nd, Maddaus MA, Johnstone DW, et al
     Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non-Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. BESSE B , Le Chevalier T
     Adjuvant Chemotherapy for Non-Small-Cell Lung Cancer: A Fading Effect?
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
143. LAND SR
     Missing Patient-Reported Outcome Data in an Adjuvant Lung Cancer Study.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
144. BARVE M , Bender J, Senzer N, Cunningham C, et al
     Induction of Immune Responses and Clinical Efficacy in a Phase II Trial of IDM-2101, a 10-Epitope Cytotoxic T-Lymphocyte Vaccine, in Metastatic Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2008;26:4418-25.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. DIEU-NOSJEAN MC , Antoine M, Danel C, Heudes D, et al
     Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.
     J Clin Oncol. 2008;26:4410-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. ANANDA S , Field KM, Kosmider S, Compston D, et al
     Patient Age and Comorbidity Are Major Determinants of Adjuvant Chemotherapy Use for Stage III Colon Cancer in Routine Clinical Practice.
     J Clin Oncol. 2008;26:4516-7.
     PubMed     Text format     Related articles   
     
     
     
147. PAULUSSEN M , Craft AW, Lewis I, Hackshaw A, et al
     Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
     J Clin Oncol. 2008;26:4385-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. COPPOLA D , Mule JJ
     Ectopic lymph nodes within human solid tumors.
     J Clin Oncol. 2008;26:4369-70.
     PubMed     Text format     Related articles   
     
     
     
149. JAFFE N , Gorlick R
     High-dose methotrexate in osteosarcoma: let the questions surcease--time for final acceptance.
     J Clin Oncol. 2008;26:4365-6.
     PubMed     Text format     Related articles   
     
     
     
150. QIU J , Choi G, Li L, Wang H, et al
     Occurrence of Autoantibodies to Annexin I, 14-3-3 Theta and LAMR1 in Prediagnostic Lung Cancer Sera.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. BRADLEY CJ , Dahman B, Given CW
     Treatment and Survival Differences in Older Medicare Patients With Lung Cancer as Compared With Those Who Are Dually Eligible for Medicare and Medicaid.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. MITRY E , Fields AL, Bleiberg H, Labianca R, et al
     Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized Trials.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. LATHAN CS , Neville BA, Earle CC
     Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer.
     J Clin Oncol. 2008;26:4347-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. TITULAER MJ , Wirtz PW, Willems LN, van Kralingen KW, et al
     Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome.
     J Clin Oncol. 2008;26:4276-81.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. HERMES A , Bergman B, Bremnes R, Ek L, et al
     Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial.
     J Clin Oncol. 2008;26:4261-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. CRINO L , Cappuzzo F, Zatloukal P, Reck M, et al
     Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study.
     J Clin Oncol. 2008;26:4253-60.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. MARUYAMA R , Nishiwaki Y, Tamura T, Yamamoto N, et al
     Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer.
     J Clin Oncol. 2008;26:4244-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. GANDARA DR , Lara PN Jr, Natale R, Belani C, et al
     Progress in small-cell lung cancer: the lowest common denominator.
     J Clin Oncol. 2008;26:4236-8.
     PubMed     Text format     Related articles   
     
     
     
159. DAHLBERG SE , Gray RJ, Johnson BE
     Gefitinib for recurrent non-small-cell lung cancer: all things are not created equal.
     J Clin Oncol. 2008;26:4233-5.
     PubMed     Text format     Related articles   
     
     
     
160. ZHU CQ , da Cunha Santos G, Ding K, Sakurada A, et al
     Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.
     J Clin Oncol. 2008;26:4268-75.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. MACK PC , Redman MW, Chansky K, Williamson SK, et al
     Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non-Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. STEWART DJ
     Gefitinib Maintenance in Stage III Non-Small-Cell Lung Cancer.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
163. KAPPERS I , Klomp HM, Burgers JA, Van Zandwijk N, et al
     Neoadjuvant (induction) erlotinib response in stage IIIA non-small-cell lung cancer.
     J Clin Oncol. 2008;26:4205-7.
     PubMed     Text format     Related articles   
     
     
     
164. KEEDY V , Wang W, Schiller J, Chada S, et al
     Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597.
     J Clin Oncol. 2008;26:4166-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. HERNDON JE 2ND , Kornblith AB, Holland JC, Paskett ED, et al
     Patient education level as a predictor of survival in lung cancer clinical trials.
     J Clin Oncol. 2008;26:4116-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
166. DE GIORGI U , Perkins GH, Cristofanilli M
     Risk of ipsilateral lung cancer after postmastectomy radiotherapy and smoking: does the possible triumph over the actual?
     J Clin Oncol. 2008;26:4044-5.
     PubMed     Text format     Related articles   
     
     
     
167. FAIRCHILD A , Harris K, Barnes E, Wong R, et al
     Palliative thoracic radiotherapy for lung cancer: a systematic review.
     J Clin Oncol. 2008;26:4001-11.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. MANEGOLD C , Gravenor D, Woytowitz D, Mezger J, et al
     Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer.
     J Clin Oncol. 2008;26:3979-86.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. WAGNER H JR
     Just enough palliation: radiation dose and outcome in patients with non-small-cell lung cancer.
     J Clin Oncol. 2008;26:3920-2.
     PubMed     Text format     Related articles   
     
     
     
170. 
     Chemotherapy in Addition to Supportive Care Improves Survival in Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 16 Randomized Controlled Trials.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. ROSS ME , Hicks J, Furman WL
     Preschool as palliative care.
     J Clin Oncol. 2008;26:3797-9.
     PubMed     Text format     Related articles   
     
     
     
172. IWANICKI-CARON I , Di Fiore F, Roque I, Astruc E, et al
     Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer.
     J Clin Oncol. 2008;26:3681-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
173. PITINI V , Arrigo C, Altavilla G
     Erlotinib in a patient with acute myelogenous leukemia and concomitant non-small-cell lung cancer.
     J Clin Oncol. 2008;26:3645-6.
     PubMed     Text format     Related articles   
     
     
     
174. FRUH M , Rolland E, Pignon JP, Seymour L, et al
     Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
     J Clin Oncol. 2008;26:3573-81.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. ORLOW I , Park BJ, Mujumdar U, Patel H, et al
     DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumors.
     J Clin Oncol. 2008;26:3560-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. PIGNON JP , Tribodet H, Scagliotti GV, Douillard JY, et al
     Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.
     J Clin Oncol. 2008;26:3552-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. BRUGAROLAS J , Lotan Y, Watumull L, Kabbani W, et al
     Sirolimus in metatastic renal cell carcinoma.
     J Clin Oncol. 2008;26:3457-60.
     PubMed     Text format     Related articles   
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: